290
Participants
Start Date
October 31, 2005
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
SCULPTRA (poly-L-lactic acid injection)
Subjects will be treated with SCULPTRA® according to the investigator's judgment, and in accordance with the SCULPTRA® package insert. Details of the exact amount and the time of administration of SCULPTRA® (date, amount, location) will be documented in the CRF at each protocol and non-protocol visit.
Sanofi-Aventis Administrative Office, Bridgewater
Bausch Health Americas, Inc.
INDUSTRY